Viatris (VTRS) Current Assets (2019 - 2026)
Viatris (VTRS) posted quarterly Current Assets of $10.9 billion for Q1 2026, up 13.45% year-over-year from $9.6 billion in Q1 2025, and up 11.52% quarter-over-quarter from $9.8 billion in Q4 2025.
Viatris (VTRS) Current Assets (2019 - 2026) Analysis & Trends
Viatris' Current Assets history runs 8 years deep, the most recent figure standing at $10.9 billion for Q1 2026.
- In Q1 2026, Current Assets rose 13.45% year-over-year to $10.9 billion; the TTM figure through Mar 2026 stood at $10.9 billion (up 13.45% YoY), while the FY2025 annual figure was $9.8 billion, up 2.82% from the prior year.
- Current Assets for Q1 2026 stood at $10.9 billion, up from $9.8 billion in the prior quarter.
- The five-year high for Current Assets was $13.0 billion in Q4 2023, with the low at $9.5 billion in Q4 2024.
- The 5-year median for Current Assets is $10.6 billion (2022), against an average of $10.8 billion.
- Peak annual rise in Current Assets reached 34.2% in 2024, while the deepest fall reached 26.63% in 2024.
- Viatris' Current Assets stood at $10.6 billion in 2022, then increased by 22.01% to $13.0 billion in 2023, then declined by 26.63% to $9.5 billion in 2024, then advanced by 2.82% to $9.8 billion in 2025, then gained by 11.52% to $10.9 billion in 2026.
- Business Quant data shows VTRS's Current Assets at $10.9 billion in Q1 2026, $9.8 billion in Q4 2025, and $10.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.06 Bn |
| Mar 31, 2026 | 10.92 Bn |
| Dec 31, 2025 | 9.79 Bn |
| Sep 30, 2025 | 9.95 Bn |
| Jun 30, 2025 | 9.77 Bn |
| Mar 31, 2025 | 9.62 Bn |
| Dec 31, 2024 | 9.52 Bn |
| Sep 30, 2024 | 11.31 Bn |
| Jun 30, 2024 | 11.79 Bn |
| Mar 31, 2024 | 12.92 Bn |
| Dec 31, 2023 | 12.98 Bn |
| Sep 30, 2023 | 10.93 Bn |
| Jun 30, 2023 | 9.78 Bn |
| Mar 31, 2023 | 9.63 Bn |
| Dec 31, 2022 | 10.64 Bn |
| Sep 30, 2022 | 10.49 Bn |
| Jun 30, 2022 | 11.18 Bn |
| Mar 31, 2022 | 11.74 Bn |
| Dec 31, 2021 | 10.90 Bn |
| Sep 30, 2021 | 11.31 Bn |